UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.107

Sortiert nach

Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias

Frontiers in immunology, 2024, Vol.15, p.1382318-1382318

2024

Link zum Volltext

Verfügbarkeit prüfen

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

Nature communications, 2015-09, Vol.6 (1), p.8143-8143, Article 8143

2015

Link zum Volltext

Verfügbarkeit prüfen

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Vaccine, 2016-09, Vol.34 (42), p.5114-5124

2016

Link zum Volltext

Verfügbarkeit prüfen

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

Virology (New York, N.Y.), 2016-07, Vol.494, p.215-224

2016

Link zum Volltext

Verfügbarkeit prüfen

Vitamin A deficiency impairs the immune response to intranasal vaccination and RSV infection in neonatal calves

Scientific reports, 2019-10, Vol.9 (1), p.15157-14, Article 15157

2019

Link zum Volltext

Verfügbarkeit prüfen

Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure

Frontiers in immunology, 2024-04, Vol.15, p.1377374-1377374

2024

Link zum Volltext

Verfügbarkeit prüfen

A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models

PloS one, 2015-03, Vol.10 (3), p.e0119509-e0119509

2015

Link zum Volltext

Verfügbarkeit prüfen

Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG

Proceedings of the National Academy of Sciences - PNAS, 2008-12, Vol.105 (52), p.20822-20827

2008

Link zum Volltext

Verfügbarkeit prüfen

Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus

Frontiers in immunology, 2024-05, Vol.15, p.1374818-1374818

2024

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens

Journal of virology, 2022-04, Vol.96 (7), p.e0220121-e0220121

2022

Link zum Volltext

Verfügbarkeit prüfen

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Antiviral research, 2019-08, Vol.168, p.9-17

2019

Link zum Volltext

Verfügbarkeit prüfen

A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge

Journal of virology, 2017-06, Vol.91 (11)

2017

Link zum Volltext

Verfügbarkeit prüfen

A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines

Nature medicine, 2006-08, Vol.12 (8), p.905-907

2006

Link zum Volltext

Verfügbarkeit prüfen

Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes

The Journal of experimental medicine, 2015-05, Vol.212 (5), p.699-714

2015

Link zum Volltext

Verfügbarkeit prüfen

Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats

Journal of virology, 2021-02, Vol.95 (6)

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice

PloS one, 2012-05, Vol.7 (5), p.e36812-e36812

2012

Link zum Volltext

Verfügbarkeit prüfen

A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease

PloS one, 2011-07, Vol.6 (7), p.e21823

2011

Link zum Volltext

Verfügbarkeit prüfen

Animal models of respiratory syncytial virus infection

Vaccine, 2017-01, Vol.35 (3), p.469-480

Taylor, Geraldine

2017

Link zum Volltext

Verfügbarkeit prüfen

A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease

The Journal of immunology (1950), 2016-02, Vol.196 (4), p.1721-1731

2016

Link zum Volltext

Verfügbarkeit prüfen

Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma

Nature medicine, 2012-10, Vol.18 (10), p.1525-1530

2012

Link zum Volltext

Verfügbarkeit prüfen

Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease

Journal of virology, 2015-02, Vol.89 (3), p.1564-1578

2015

Link zum Volltext

Verfügbarkeit prüfen

Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy

Vaccine, 2015-10, Vol.33 (41), p.5371-5379

2015

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c Mice

Journal of Virology, 2010-09, Vol.84 (18), p.9632-9636

2010

Link zum Volltext

Verfügbarkeit prüfen

Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection

Frontiers in immunology, 2020-07, Vol.11, p.1673-1673

2020

Link zum Volltext

Verfügbarkeit prüfen

Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein

mAbs, 2021-01, Vol.13 (1), p.1955812-1955812

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.107

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.958)
Mit Volltextzugriff
(1.816)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.821)
Life Sciences & Biomedicine
(1.720)
Respiratory Syncytial Virus
(1.409)
Animals
(1.400)
Immunology
(1.253)
Mice
(710)
Respiratory Syncytial Viruses - Immunology
(656)
Respiratory Syncytial Virus Infections - Immunology
(554)
Microbiology
(536)
Mice, Inbred Balb C
(524)
Female
(520)
Viruses
(494)
Virology
(489)
Infections
(474)
Biological And Medical Sciences
(458)
Vaccines
(403)
Infectious Diseases
(399)
Medicine, Research & Experimental
(366)
Research & Experimental Medicine
(366)
Cattle
(357)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccine
(204)
Journal Of Virology
(133)
The Journal Of Infectious Diseases
(125)
Vaccines
(100)
Plos One
(72)
The Journal Of Immunology
(72)
Frontiers In Immunology
(57)
American Journal Of Veterinary Research
(50)
Journal Of General Virology
(50)
Veterinary Immunology And Immunopathology
(33)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(29)

Menü

Weitere Dienste

Einstellungen

Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

Vitamin A deficiency impairs the immune response to intranasal vaccination and RSV infection in neonatal calves

Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure

A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models

Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG

Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus

Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge

A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines

Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes

Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats

Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice

A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease

Animal models of respiratory syncytial virus infection

A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease

Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma

Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease

Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy

Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c Mice

Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection

Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein

Aktive Filter

Suchergebnisse filtern